Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: GlobeNewswire
-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial Revenue in 24 Months, Contributing to 2029 Revenue CAGR -- CHASKA, Minn., March 23, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it has signed a CDMO manufacturing services agreement with a new aesthetics customer for an established, market-approved product. Under the terms of the agreement, Lifecore will perform technical transfer services including process performance qualification (“PPQ”) batches for a sterile product that the customer currently manufactures in-house, outside the U.S. Initial outsourced manufacturing aims to increase production for products sold in the U.S. market. Lifecore believes the product may generate commercial
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical (LFCR) was upgraded by Barrington Research from "market perform" to "outperform". They now have a $5.50 price target on the stock.MarketBeat
- Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]Seeking Alpha
- Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance